Marc D. Kozin, Director at Flex Pharma, Inc. (FLKS), bought 4,500 shares at $11.38 ($51K) on 2015-11-19, disclosed to the SEC on 2015-11-23.
Open-market purchase of $51k FLKS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| UFPT | SELL | 2021-03-10 | $1.0M | — | Filing → |
| UFPT | SELL | 2020-03-11 | $398K | — | Filing → |
| UFPT | SELL | 2019-09-12 | $450K | — | Filing → |